Dr. Robert Montgomery, Director of the NYU Langone Transplant Institute, presenting at the 2024 Spring Clinical Meetings Xenotransplant Session. The Second Annual Richard Slayman Clinical Xenotransplantation Workshop is a groundbreaking kidney transplant meeting that brought together experts to discuss the future of xenotransplantation, including the National Kidney Foundation's own Heather Murphy, who represented the patient perspective. What is Xenotransplantation? Xenotra

People living with chronic kidney disease (CKD) often have other health conditions too, like diabetes, heart disease, obesity, or heart failure. Together, these interconnected conditions are known as cardiovascular-kidney-metabolic (CKM) syndrome. The good news? Healthcare professionals have more treatment options than ever before to help protect kidney and heart health. The challenge is figuring out how to use those treatments together. Which medications should come first? W

More than 1 in 7 U.S. adults are estimated to have chronic kidney disease (CKD), yet about 9 in 10 don't know they have it. Because kidney disease often develops without noticeable symptoms, many people are not diagnosed until the disease has already progressed. By then, treatment options may be more limited. Advancing Early Disease Care The good news is that early detection can make a difference. When CKD is found early, people have more opportunities to slow disease progres

Managing chronic kidney disease (CKD) has become increasingly complex, due in part to a rapid and promising increase in the number of pharmacologic therapies now available to slow CKD progression and reduce its associated cardiovascular risk. To help address these challenges, the National Kidney Foundation recently convened a multidisciplinary scientific workshop focused on developing practical, patient-centered approaches to combination therapy in CKD. Cardiovascular-Kidney